All posts by imreal

The NABR Names Aventis Systems Among the Best and Brightest Companies to Work For in the Nation


Best and Brightest Award for Aventis Systems, Inc.

We find that there’s an interplay between taking care of your talent and taking care of your customers.

The National Association for Business Resources (NABR) has released their Summer 2022 Best and Brightest Companies To Work For in the Nation, and Aventis Systems, Inc. was among the winners. All winners were evaluated by an independent research firm, which assessed a number of key metrics with Aventis Systems versus other nationally recognized companies.

With over 20 years of experience conducting the Best and Brightest competitions, the NABR has identified numerous best human resource practices and provided benchmarking for companies with an aptitude for leadership in employment standards. The Best and Brightest Companies to Work For in the Nation offers four timelines of applications throughout a given year: spring, summer, fall and winter.

In the case of the aforementioned award, NABR honored 175 winning organizations from across the nation from a pool of 1,400 nominations for the summer of this year. The proud winners are slated to be honored during the virtual Illuminate Business Summit week in November 2022 as well as in the spring of next year.

Aventis Systems is headquartered in Atlanta, Georgia where it caters to smaller businesses with hardware, system and application software, plus custom configurations. In 2019, Aventis Systems founded Cortavo as a managed IT services provider. Cortavo is currently the only managed IT services provider to offer an IT solution that handles technology — completely — in a simple plan. And like Aventis Systems, they serve businesses of all sizes.

The Elite categories under which Aventis Systems was evaluated include: Compensation, Benefits and Employee Solutions; Employee Enrichment, Engagement and Retention; Employee Education and Development; Recruitment, Selection and Orientation; Employee Achievement and Recognition; Communication and Shared Vision; Diversity and Inclusion; Work-Life Balance; Community Initiatives; Strategic Company Performance, and the Best of the Best: Small Business, Medium Business and Large Business.

To meet this challenge, both Aventis Systems and Cortavo offer a generous array of perks that distinguish them from the competition while attracting and retaining top-flight talent.


  • Unlimited PTO
  • Remote work
  • Incentivized airline tickets
  • Corporate personal trainer
  • Company cell phone plan
  • Student debt relief program
  • Team building events
  • Volunteer opportunities
  • Tesla auto program
  • Child care stipend
  • Full-time employees are eligible for medical, dental and vision insurance
  • Unlimited snacks and drinks

When learning about securing this award yet again, Tiffany Bloomer, President of Aventis Systems and Cortavo noted their 100% customer-centric model and outstanding employee benefits program. “We find that there’s an interplay between taking care of your talent and taking care of your customers. You cannot do one without the other. When our team is undistracted and happy in their work, they pass that energy onto the customers in everything they do. This has allowed us to grow and make more happy employees who do the same.”

All 2022 Best and Brightest Company to Work For winners will be featured in the online edition of Corp! Magazine as well as in the Wall Street Journal.

More About Aventis Systems

Headquartered in Atlanta, GA, Aventis Systems, Inc. offers custom IT solutions to build and operate complete physical and virtual infrastructures. Their comprehensive solutions include hardware, system and application software, along with an array of in-depth managed services including Cortavo, an all-inclusive Managed Services Provider that offers all the hardware, software and cloud services to address small business technology needs and challenges at a flat monthly fee. Since 2008, thousands of small business owners have entrusted Aventis Systems as their preferred IT provider because they “Get IT Done.”

Call 1-855-AVENTIS, visit http://www.AventisSystems.com or connect with Aventis Systems on LinkedIn, Twitter or Facebook.

More About Cortavo

Cortavo is the only all-inclusive managed IT solution providing unlimited service desk support, cybersecurity, internet connectivity, cloud data storage, computer hardware and software necessary to manage small to medium-sized business technology needs at a flat monthly fee. Cortavo is based in Atlanta, GA and supports thousands of small business employees throughout the southeastern United States. Their service is award-winning, garnering recognitions from Inc. 5000, 2021 Big Awards for Business, being named The #1 Managed IT Services Provider in Atlanta by Clutch.com, and now securing the Best and Brightest award.

For customer service or media inquiries, please call 1-866-267-8286, visit http://www.Cortavo.com to connect with Cortavo.

Reach Cortavo on social media:

LinkedIn

Twitter

Facebook

Share article on social media or email:



How to Ensure Site Success Through This New Era of Increased Decentralized Trial Adoption, Upcoming Webinar Hosted by Xtalks


The world is in a new decentralized trial era, one in which decentralized solutions are more well-known and accepted, being built into trials proactively.

For many sites the recent increase in utilization of decentralized clinical trials (DCTs) was a forced relationship, being implemented in response to the pandemic, and rushed to rescue trials that would have otherwise failed. Now, the world is in a new decentralized trial era, one in which decentralized solutions are more well-known and accepted, being built into trials proactively. As a result, more sites are being asked to not only learn how to implement these solutions but also know how to successfully utilize decentralized trial elements. Appropriate implementation and successful delivery is no small task!

After 16 years of delivering decentralized elements in trials, MRN has become well-versed with the burdens and issues that sites face when implementing DCTs and the challenges they must overcome all while keeping the patient’s care their top priority. In response, they built an ecosystem of processes and teams to help sites become more successful DCT users.

In this webinar, the featured speakers will share their experience working with sites and delivering decentralized clinical trials to ensure critical data is collected, trials realize the full value of DCTs, and sites can run these trials more successfully.

Register for this webinar to learn about ensuring site success through this new era of increased decentralized trial adoption.

Join experts from Medical Research Network (MRN), Stuart Redding, CEO; and Kerry Leyden, Director Site Relationship Management, for the live webinar on Thursday, October 27, 2022, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit How to Ensure Site Success Through This New Era of Increased Decentralized Trial Adoption.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

BioFactura’s BFI-751, a Biosimilar Ustekinumab, Demonstrates Pharmacokinetic (PK) Bioequivalence to Stelara® in Phase 1 Study


News Image

“Meeting the primary endpoint of clinical bioequivalence in this trial, along with our bioanalytical comparative data, puts BFI-751 on the way to regulatory approval and commercial launch”, Jeffrey N. Hausfeld MD, MBA

BioFactura Inc. has announced today the completion of the pivotal pharmacokinetic comparability clinical trial for its Ustekinumab Biosimilar (BFI-751). The clinical trial was conducted in two sites in Australia and one site in New Zealand. BioFactura developed BFI-751 using its proprietary NS0 host cell line-based StableFastTM Biomanufacturing Platform.

Ustekinumab is a targeted monoclonal antibody directed against the common p40 subunit of the naturally occurring proteins interleukin (IL)-12 and IL-23, which regulate the immune system. The reference product, Stelara ®, has been approved for the treatment of plaque psoriasis, active psoriatic arthritis, Crohn’s disease, and ulcerative colitis and is projected to have global market sales at $10B in 2023 prior to patent expiry.

A total of 226 subjects were enrolled and randomly assigned 1:1:1 to receive BFI-751, EU-STELARA® and US-STELARA®. Pairwise comparisons between the three treatments all met the standard bioequivalence criteria that the 90% CI (Confidence Interval) of the geometric mean ratios of AUCinf, AUC0-tlast and Cmax of Ustekinumab lay completely within the acceptance interval of 80% – 125%. Clearance and elimination rates were shown to be comparable across the three treatment arms.

Secondary endpoints met included no marked differences in the safety and tolerability profile for subjects receiving BFI-751 as compared to EU- or US-STELARA®. Similar immunogenicity profiles were seen with EU- and US-STELARA®. BFI-751 showed a lower immunogenicity rate at all time points in the assay compared with EU- and US-STELARA®.

BioFactura intends to conduct a confirmatory safety and efficacy study in patients to pave the way for global registration.

“Unlike novel drugs, a phase 1 trial for a biosimilar asset is called a pivotal pharmacokinetic study because it quantifies and compares how a biosimilar drug is absorbed and metabolized in relation to the innovator products. The establishment of meeting the primary endpoint of clinical bioequivalence in this trial, along with our fingerprint bioanalytical comparative data, puts BioFactura well on the way to regulatory approval and commercial launch of BFI-751. My gratitude goes out to all those who participated in the trial and supported the completion of this study, said Jeffrey N. Hausfeld MD, MBA, Chairman of the Board and Chief Medical Officer of BioFactura.”

Dr. Darryl Sampey, President and CEO, stated, “The successful completion of BioFactura’s first clinical study marks a capstone for the company. This product was conceived, created and manufactured entirely in-house by the most capable and hardworking team of people I have ever known. A sincere thanks to all who worked tirelessly over many years to bring us this remarkable outcome!”

About BioFactura, Inc.

BioFactura, Inc. (Frederick MD) develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 18 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases. http://www.biofactura.com

Share article on social media or email:

Healthcare M&A Activity Remained Strong in Q3:22, According to Market Data Captured By Irving Levin Associates, LLC


News Image

“Healthcare M&A activity is showing no signs of slowing,” said Glenn Kalinoski, Editor of Healthcare at Irving Levin Associates. “The two consecutive quarters of shrinking GDP and rising interest rates have not produced any slowdown in deal volumes.”

Healthcare merger and acquisition activity remained extremely active during the third quarter of 2022, with 734 publicly announced deals, according to new data captured by Irving Levin Associates on its LevinPro HC platform. While some sectors, like Hospitals and Managed Care, had a significant increase in activity, others like Medical Devices experienced a slowdown. Transaction volume in Q3:22 remained virtually the same with deal totals in Q2:22, but increased by nearly 20% compared with the third quarter in 2021.

Healthcare M&A deal value totals revealed a slight increase from $57.74 billion in Q2:22 to $58.2 billion during Q3:22. The total disclosed dollars spent fell dramatically from the $145 billion reported in Q3:21.

“Healthcare M&A activity is showing no signs of slowing,” said Glenn Kalinoski, Editor of Healthcare at Irving Levin Associates. “The two consecutive quarters of shrinking GDP and rising interest rates have not produced any slowdown in deal volumes.”

The Managed Care sector experienced a 78% increase, with 9 deals in Q2:22 and 16 transactions in Q3:22. The Hospitals sector had 12 deals in Q2:22 and 20 in Q3:22, resulting in a 67% increase in activity. Medical Devices reported a 44% decrease in deal totals, dipping from 45 deals in Q2:22 to 25 deals in Q3:22.

The sector with the highest announced deal activity in Q3:22 was Physician Medical Groups with 170 deals followed by 140 for Other Services, which include staffing companies, ambulatory surgical centers, urgent care centers and other ancillary healthcare services.

Private equity activity has been strong and consistent all year, pushing ahead of investment totals in 2021. During Q3:22, there were 245 transactions made by private equity firms or their portfolio companies, representing a 12% increase over Q3:21 when 217 transactions involved private equity.

“Private equity continues to see value in the healthcare sector,” Kalinoski said. “Opportunities to maximize return on invested capital can be found in numerous healthcare subsectors.”

Notable deals that were reported during the third quarter included CVS Health’s acquisition of Signify Health for $8 billion and Remgro Limited’s purchase of Mediclinic International Ltd. for $7.4 billion. Also, Chubb acquired Cigna Corporation’s life, accident and supplemental benefits businesses for $5.4 billion.

All quarterly results are published in The Health Care M&A Report, which is part of the Irving Levin Associates and LevinPro investment research source. For information, or to order the reports, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has offices in New Canaan, Connecticut, and North Bethesda, Maryland. The company publishes research reports and newsletters and maintains databases on the healthcare and senior housing M&A markets.

Share article on social media or email:

Jily SkinLab, An Innovative Medspa, Joins The Daywel Family of Companies At Miller’s Pharmacy


Jily SkinLab is thrilled to offer this groundbreaking technology.

Jily SkinLab is thrilled to offer this groundbreaking technology.

“Miller’s has been at the forefront of covid testing and vaccination while promoting many products and treatments that advance health and wellness. We are now adding beauty to Daywel’s core mission to help clients embrace living.”

Daywel, is proud to announce that it has opened Jily SkinLab — an innovative medspa — located in the historic Miller’s Pharmacy building in Wyckoff, New Jersey.

Jily SkinLab offers groundbreaking skin solutions to give your skin the attention it deserves with medical grade treatments performed by highly-trained aestheticians. Jily also offers a line of clinical skincare products and customized prescriptions — all formulated by the trusted pharmacists at Miller’s.

The Jily Skin products have been developed from the ground up with a deep understanding of the structure and chemistry of the skin. The results are of superior quality and efficacy, helping men and women achieve and maintain optimal skin health. The Jily Skin products are manufactured in the company’s own state-of-the-art facility to oversee every step of the production process. Jily SkinRx customized products (to be available in 60 days) will be dispensed separately through the company’s own nationally accredited compounding facility, which is licensed in all 50 states.

“We are pleased to be able to serve our community in yet another way,” states Baruch Halpern, CEO of Daywel. “Miller’s has been at the forefront of covid testing and vaccination while promoting many products and treatments that advance health and wellness. We are now adding beauty to Daywel’s core mission to help clients embrace living.”

David Miller, Grandson of the Miller’s Pharmacy founder, also expresses his support and pride in this new endeavor:

“I wish my grandparents were alive today to see our advanced offerings. My grandfather started Miller’s (now part of Daywel) in 1919 as an apothecary, to deliver health solutions. Here we are 100 years later and Daywel’s holistic focus on wellness, fitness, and beauty is something that he would have been very proud of.”

To celebrate this opening, Jily SkinLab is running incredible sweepstakes. Participants can win thousands of dollars in services, including Botox, facials, Morpheus8 microneedling, Lumecca IPL therapy, and Diolaze hair removal.

Please follow the company’s Instagram @jilyskinlab and visit the new website at http://www.jilyskinlab.com for more information and special offers.

Jily SkinLab at Miller’s Pharmacy is located at 678 Wyckoff Avenue in Wyckoff, NJ and is open 9:30 AM – 6:00 PM Monday through Friday and 9:00AM – 4:00PM on Saturday.

Share article on social media or email:

F. C. Vogt announces the release of ‘Four Legs and a Stretcher’


News Image

Over the years, F. C. Vogt has pursued truth and spirituality in numerous ways. This has lead him down various paths of learning and experience. He wanted to write about these in a way that might be helpful to fellow travelers on this journey. He wanted to leave whatever mark he could in the pursuit of spiritual formation, as it has been so important to him. Writing about them in the wide lens of faith gave him a broad context that would include all of what he considers as necessary components of a rich spiritual life.    

“Four Legs and a Stretcher: Constructing an Intentional Faith that Leads to Godliness” (published by Archway Publishing) is a metaphor about the intentional efforts one needs to make for developing an intimate and meaningful relationship with God, which Vogt considers to be the purpose of faith. A second metaphor woven through the chapters of the book describe growing in faith as a spiritual journey that can be purposefully and successfully navigated if one is properly equipped. Throughout the book, readers will find anecdotes and highlights from Vogt’s life that will make their journey of faith relevant and achievable.

“Faith is God’s method for bringing humanity into consecrated fellowship with Him. Relative to this, faith is, at its core, about the presence of God in our lives. Faith determines the degree to which our knowledge of God develops into a relationship with God. Faith measures how we respond to that, deepen our understanding of it, and change our lives because of it,” Vogt points out.

When asked what he wants readers to take away from the book, Vogt answers, “God wants every part of us, but especially our hearts. And a heart centered practice of building and growing in godly faith is what I hope to convey through the scriptures, some thoughts by other writers, some metaphors that have helped me, and some stories about the personal way God has been involved in drawing me to Him. I pray that the words on these pages will speak to your heart and have a helpful effect on your perspective and understanding of your faith journey.” For more details about the book, please visit https://www.archwaypublishing.com/en/bookstore/bookdetails/839761-four-legs-and-a-stretcher

“Four Legs and a Stretcher: Constructing an Intentional Faith that Leads to Godliness”

By F. C. Vogt

Hardcover | 5.5 x 8.5in | 266 pages | ISBN 9781665727044

Softcover | 5.5 x 8.5in | 266 pages | ISBN 9781665727051

E-Book | 266 pages | ISBN 9781665727068

Available at Amazon and Barnes & Noble

About the Author

F. C. Vogt has been a professional furniture conservator and maker for almost 50 years. He has been pursuing spiritual truth since his teenage years, studying philosophy, apologetics, and systematic theology both academically and informally. This is his first book.

Simon & Schuster, a company with nearly ninety years of publishing experience, has teamed up with Author Solutions, LLC, the worldwide leader in self-publishing, to create Archway Publishing. With unique resources to support books of all kind, Archway Publishing offers a specialized approach to help every author reach his or her desired audience. For more information, visit archwaypublishing.com or call 844-669-3957.

Share article on social media or email:

Sandra Zirkle’s newly released “Know God, No Fear” is an empowering message of the comfort and strength one can draw from relying on God


News Image

“Know God, No Fear”: a potent reminder of God’s connection to all. “Know God, No Fear” is the creation of published author Sandra Zirkle.

Zirkle shares, “we all experience fear in life, and that fear is real, but living in fear is to live less than the abundant life God has to offer us. See how getting to know God through God’s Word can take away fears and bring the joy, peace, and love of God that we were meant to have in life. See God protect and provide through fear and grow one’s ability to experience His peace and presence in whatever lies ahead. Using Scripture and personal experiences, see how you too can combat the lies of the enemy that create fear and, instead, walk in the joy and peace that Jesus make available to us.”

Published by Christian Faith Publishing, Sandra Zirkle’s new book will encourage and inspire as readers learn about the fulfillment that awaits when fears are released.

Zirkle shares in hopes of helping others on their spiritual journey to living in abundance and fulfillment as God intended.

Consumers can purchase “Know God, No Fear” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Know God, No Fear,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Scott D. Lurie, DMD of World Class Smiles Named 2022 NJ Top Dentist


Scott D. Lurie, DMD

Scott D. Lurie, DMD

Scott D. Lurie, DMD of World Class Smiles has been reviewed and approved by NJ Top Dentists for 2022. With three decades worth of experience, Dr. Scott D. Lurie of World Class Smiles is able to extend his expertise with ease. Whether you need a filling, a bridge, or reconstruction of your entire mouth, Dr. Lurie has you covered.

Dr. Lurie emphasizes patient satisfaction and going the extra mile to treat every patient like family.

His experience matched with the level of communication between him and his patients are what leads to the best treatment outcomes. In fact, Dr. Lurie’s commitment to excellence is recognized by both his team members and patients alike.

In addition, Dr. Lurie stays committed to continuing education so that he can provide the latest in dental treatment.

To learn more about Dr. Scott D. Lurie and World Class Smiles, please visit: https://njtopdocs.com/nj-dentists/drscottdlurie/

—

About Us

NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Joan Hope’s newly released “Messages He Gave Me” is an engaging collection of sermons written and delivered throughout the author’s ministry service


News Image

“Messages He Gave Me”: a selection of impactful sermons in five sections, – Women and Grandparents, Spiritual Growth, Christian Living, Encouragement, and Christmas Blessings.    

Topics include Grandparenting, Complaining, The Best Places to Live, Keeping Up Appearances, Christians Under the Influence, Helping God and Window Shopping.

It is written for easy reading in the conversational style in which the messages were preached. All messages are Bible based with appropriate supporting references, suitable for individual or group Bible Study. They include challenging questions that encourage introspection, and hopefully motivate the readers to pursue a close, meaningful personal relationship with God.

Hope shares, “Joan Hope was born in Guyana in South America. She grew up in the Beterverwagting/ Triumph area and attended elementary and high school in Georgetown.

“She was part of the leadership of the youth fellowship of the Elim Pentecostal Church on Albert Street.

“She lived in Nassau, Bahamas, attended Bahamas Faith Ministries, was a part of BFM’s Woman of the Word and a member of the island’s Women’s Aglow Fellowship. There she became aware of her heart for Women’s Ministry.

“In Georgia, attends The Redeemed Christian Church of God, in Douglasville and is a part of the Women’s Ministry leadership.

“Joan, a professional teacher for many years, was a lecturer in microbiology and head of the Medical Technology Department at the University of Guyana. In Nassau Bahamas, she was head of the Science Department at Kingsway Academy. She established and still coordinates the Vacation Bible School for Children in The Redeemed Christian Church of God, Praise Chapel, Georgia. Her zeal for teaching is reflected in her sermons.

“She is truly grateful to God for the opportunities afforded her over the years to be useful in various areas of His kingdom.”

Published by Christian Faith Publishing, Joan Hope’s new book brings a thoughtful offering to add to anyone’s daily faith practices.

Hope shares with the intent of aiding others in their personal spiritual journey as she delivers one thought-provoking message after another.

Consumers can purchase “Messages He Gave Me” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Messages He Gave Me,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Aaron Hunter EL’s newly released “Jesus’s Death on the Cross Was a Parable Like Every Other Parable (of a Surety, They Killed Him Not)” is an engaging legal discussion


News Image

“Jesus’s Death on the Cross Was a Parable Like Every Other Parable (of a Surety, They Killed Him Not)”: a helpful resource for students of both God’s word and the legal system. “Jesus’s Death on the Cross Was a Parable Like Every Other Parable (of a Surety, They Killed Him Not)” is the creation of published author Aaron Hunter EL, a Moorish-American citizen and native to the Americas, Illinois, who has written six books with only four published. He is the father of four daughters.

Hunter shares, “The Bible—being political, social, industrial, commercial, and legal—is a greatly misunderstood book because it is seldomly taught that all of these is what makes up religion—religion being a complete way of life!

“This book gives the legal understanding of the parables in the Bible as applied to today’s legal system in America. It also gives a present-day understanding of the biblical tribes and who they are in the present day with a legal understanding of the third degree of freemasonry and full insight on Moorish-American law.”

Published by Christian Faith Publishing, Aaron Hunter EL’s new book brings an engaging and articulate discussion of law and God’s word to life.

Consumers can purchase “Jesus’s Death on the Cross Was a Parable Like Every Other Parable (of a Surety, They Killed Him Not)” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Jesus’s Death on the Cross Was a Parable Like Every Other Parable (of a Surety, They Killed Him Not),” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email: